SPX3,647.29-7.75 -0.21%
DIA291.30-1.42 -0.49%
IXIC10,829.50+26.58 0.25%

ASLAN Pharmaceuticals 启动 Eblasakimab 在特应性皮炎患者中的试验

ASLAN Pharmaceuticals 启动 Eblasakimab 在特应性皮炎患者中的试验

MT Newswires · 09/14/2022 04:04

Please log in to view news